| Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA. LI. CA database A Vitale, G Svegliati-Baroni, A Ortolani, M Cucco, GV Dalla Riva, ... Gut 72 (1), 141-152, 2023 | 91 | 2023 |
| Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis A Zanetto, F Pelizzaro, E Campello, C Bulato, L Balcar, W Gu, S Gavasso, ... Journal of Hepatology 78 (2), 301-311, 2023 | 57 | 2023 |
| Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept A Vitale, G Cabibbo, M Iavarone, L Viganò, DJ Pinato, FR Ponziani, Q Lai, ... The Lancet Oncology 24 (7), e312-e322, 2023 | 49 | 2023 |
| Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens M Fassan, C Mescoli, M Sbaraglia, V Guzzardo, FP Russo, R Fabris, ... Pathology-Research and Practice 221, 153451, 2021 | 39 | 2021 |
| Liquid biopsy in hepatocellular carcinoma: where are we now? F Pelizzaro, R Cardin, B Penzo, E Pinto, A Vitale, U Cillo, FP Russo, ... Cancers 13 (9), 2274, 2021 | 30 | 2021 |
| Machine learning in liver transplantation: a tool for some unsolved questions? A Ferrarese, G Sartori, G Orrù, AC Frigo, F Pelizzaro, P Burra, M Senzolo Transplant International 34 (3), 398-411, 2021 | 28 | 2021 |
| Hepatectomy versus sorafenib in advanced nonmetastatic hepatocellular carcinoma: a real-life multicentric weighted comparison S Famularo, M Donadon, F Cipriani, F Giuliante, S Ferri, C Celsa, ... Annals of Surgery 275 (4), 743-752, 2022 | 25 | 2022 |
| Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications A Zanetto, E Campello, F Pelizzaro, F Farinati, P Burra, P Simioni, ... Liver International 42 (6), 1229-1240, 2022 | 24 | 2022 |
| Capecitabine in advanced hepatocellular carcinoma: A multicenter experience F Pelizzaro, A Sammarco, V Dadduzio, D Pastorelli, P Giovanis, C Soldà, ... Digestive and Liver Disease 51 (12), 1713-1719, 2019 | 24 | 2019 |
| The risk of malignancies in celiac disease—a literature review F Pelizzaro, I Marsilio, M Fassan, F Piazza, B Barberio, A D’Odorico, ... Cancers 13 (21), 5288, 2021 | 22 | 2021 |
| Pattern of macrovascular invasion in hepatocellular carcinoma M Guarino, A Cucchetti, G Pontillo, F Farinati, F Benevento, GL Rapaccini, ... European Journal of Clinical Investigation 51 (7), e13542, 2021 | 20 | 2021 |
| Management of hepatocellular carcinoma recurrence after liver transplantation F Pelizzaro, M Gambato, E Gringeri, A Vitale, U Cillo, F Farinati, P Burra, ... Cancers 13 (19), 4882, 2021 | 19 | 2021 |
| Treatment of hepatocellular carcinoma with immune checkpoint inhibitors and applicability of first-line atezolizumab/bevacizumab in a real-life setting MC Plaz Torres, Q Lai, F Piscaglia, E Caturelli, G Cabibbo, E Biasini, ... Journal of Clinical Medicine 10 (15), 3201, 2021 | 19 | 2021 |
| Monofocal hepatocellular carcinoma: How much does size matter? F Pelizzaro, B Penzo, G Peserico, A Imondi, A Sartori, A Vitale, U Cillo, ... Liver International 41 (2), 396-407, 2021 | 13 | 2021 |
| Impact and novel perspective of immune checkpoint inhibitors in patients with early and intermediate stage HCC L Marzi, A Mega, S Gitto, F Pelizzaro, A Seeber, G Spizzo Cancers 14 (14), 3332, 2022 | 12 | 2022 |
| Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients F Pelizzaro, A Vitale, A Sartori, A Vieno, B Penzo, FP Russo, AC Frigo, ... Cancers 13 (4), 897, 2021 | 11 | 2021 |
| Transarterial chemoembolization for hepatocellular carcinoma in clinical practice: temporal trends and survival outcomes of an iterative treatment F Pelizzaro, S Haxhi, B Penzo, A Vitale, EG Giannini, V Sansone, ... Frontiers in Oncology 12, 822507, 2022 | 10 | 2022 |
| Impact of SARS-CoV-2 pandemic on the management of patients with hepatocellular carcinoma M Guarino, V Cossiga, M Capasso, C Mazzarelli, F Pelizzaro, R Sacco, ... Journal of Clinical Medicine 11 (15), 4475, 2022 | 9 | 2022 |
| Circulating MicroRNA-21 and MicroRNA-122 as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization F Pelizzaro, R Cardin, A Sartori, A Imondi, B Penzo, C Aliberti, A Ponzoni, ... Biomedicines 9 (8), 890, 2021 | 9 | 2021 |
| A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: a multicenter study G Marasco, F Poggioli, A Colecchia, G Cabibbo, F Pelizzaro, EG Giannini, ... Cancers 13 (11), 2677, 2021 | 9 | 2021 |
